Financial reports
10-K
2023 FY
Annual report
29 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
24 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
18 Mar 22
10-Q
2021 Q3
Quarterly report
10 Nov 21
Current reports
8-K
Regulation FD Disclosure
23 Apr 24
8-K
CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
5 Apr 24
8-K
Regulation FD Disclosure
4 Apr 24
8-K
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
28 Mar 24
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
18 Mar 24
8-K
Regulation FD Disclosure
5 Mar 24
8-K
Entry into a Material Definitive Agreement
28 Feb 24
8-K
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board
7 Feb 24
8-K
Entry into a Material Definitive Agreement
2 Feb 24
8-K
CervoMed to Participate in the Emerging Growth Conference 66
5 Jan 24
Registration and prospectus
S-8
Registration of securities for employees
29 Sep 23
425
Business combination disclosure
14 Aug 23
425
Business combination disclosure
9 Aug 23
425
Business combination disclosure
3 Aug 23
425
Business combination disclosure
3 Aug 23
425
Business combination disclosure
31 Jul 23
424B3
Prospectus supplement
13 Jul 23
425
Business combination disclosure
19 May 23
Proxies
DEFA14A
Additional proxy soliciting materials
16 Dec 22
PRRN14A
Revised preliminary proxy statement filed by non-management
6 Dec 22
DEFA14A
Additional proxy soliciting materials
5 Dec 22
DEFC14A
Proxy in contested solicitation
5 Dec 22
PRRN14A
Revised preliminary proxy statement filed by non-management
2 Dec 22
DEFA14A
Additional proxy soliciting materials
1 Dec 22
PRER14A
Preliminary revised proxy
1 Dec 22
PRER14A
Preliminary revised proxy
28 Nov 22
PREC14A
Preliminary proxy with contested solicitation
23 Nov 22
PREC14A
Preliminary proxy with contested solicitation
18 Nov 22
Other
EFFECT
Notice of effectiveness
14 Jul 23
SEC STAFF
SEC staff action: Order
13 Jul 23
CORRESP
Correspondence with SEC
12 Jul 23
CORRESP
Correspondence with SEC
11 Jul 23
UPLOAD
Letter from SEC
5 Jul 23
CORRESP
Correspondence with SEC
22 Jun 23
SEC STAFF LETTER
SEC staff letter
12 Jun 23
UPLOAD
Letter from SEC
9 Jun 23
CORRESP
Correspondence with SEC
1 Dec 22
UPLOAD
Letter from SEC
30 Nov 22
Ownership
SC 13G
RA CAPITAL MANAGEMENT, L.P.
11 Apr 24
SC 13G/A
AI EIPP Holdings LLC
6 Mar 24
SC 13D/A
BOGER JOSHUA S
28 Feb 24
4
JOSHUA S BOGER
28 Feb 24
SC 13G/A
AI EIPP Holdings LLC
14 Feb 24
4
JOSHUA S BOGER
13 Feb 24
SC 13D
BOGER JOSHUA S
9 Feb 24
3
JOSHUA S BOGER
9 Feb 24
4
JOHN J ALAM
26 Jan 24
4
Kelly Blackburn
26 Jan 24